• Mer. Mag 22nd, 2024

allergy

  • Home
  • Terapia asma eosinofilo severo, mepolizumab riporta l’equilibrio

Terapia asma eosinofilo severo, mepolizumab riporta l’equilibrio

Un nuovo studio condotto da un team multidisciplinare composto da immunologi e otorini dell’Ospedale Careggi di Firenze ha investigato il ruolo degli eosinofili infiammatori nella severità clinica dell’asma grave eosinofilico…

Antibody reduces allergic reactions to multiple foods in NIH clinical trial

A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume…